Patents Assigned to Regeron, Inc.
  • Publication number: 20240148876
    Abstract: A natural absorbent excipient having multifunction developed by a twin-screw hot melt extrusion process is disclosed. The present invention discloses a natural excipient composition comprising: (a) natural coconut husk and/or coir pith powder from the husk of coconut, the fruit of Cocos nucifera; and (b) at least one polyol compound consisting of glycerol, sorbitol, polyethene glycol (PEG), propylene glycol (PG), and combinations thereof, wherein the weight ratio of (a) to (b) is in the range of 1:1-6:4.
    Type: Application
    Filed: December 2, 2022
    Publication date: May 9, 2024
    Applicant: REGERON, INC.
    Inventor: Kailas Kalicharan MORAVKAR
  • Patent number: 10822382
    Abstract: Liposomal and/or nano-liposomal encapsulated peptides of HSP90a, HPf polypeptide (115 aa) and novel polypeptides HPf?C1 (101 aa) and HPf?C2 (87 aa), and methods for manufacturing/preparing and using the compositions, are disclosed. Chimeric fusion proteins that include HSP90a, HPf, HPf?C, HPf?C2 polypeptide, or combinations thereof, are presented. Transformed cell lines and expression vectors capable of expressing the chimeric fusion proteins, are provided. Methods for producing large amounts of recombinant HSP90a, HPf polypeptide, HPf?C1 or HPf?C2 polypeptide, using expression vectors and transformed cell lines, are described.
    Type: Grant
    Filed: April 12, 2018
    Date of Patent: November 3, 2020
    Assignee: Regeron, Inc.
    Inventors: Kibum Nam, Kyunyoung Lee, Youngwook Cho, Dahlkyun Oh
  • Patent number: 9956263
    Abstract: Liposomal and/or nano-liposomal encapsulated HSP90a, HPf polypeptide (115 aa) and novel polypeptides HPf ?C1 (101 aa) and HPf?C2 (87 aa), as well as methods for manufacturing/preparing and using the compositions, are disclosed. Chimeric fusion proteins that include an HSP90a, HPf-polypeptide, HPf ?C1 or HPf?C2 polypeptide are presented. Transformed cell lines and expression vectors capable of expressing the chimeric fusion proteins, are provided. Methods for producing large amounts of recombinant HSP90a, HPf polypeptide, HPf ?C1 or HPf?C2 polypeptide, using expression vectors and transformed cell lines, are described. Topical and other delivery form preparations and methods for using the preparations, including methods for improving skin conditions (atopic dermatitis, wrinkles, skin elasticity, dark spots (over pigmentation), overall skin rejuvenation, skin ageing) for therapeutic and cosmeceutical uses are presented.
    Type: Grant
    Filed: August 11, 2014
    Date of Patent: May 1, 2018
    Assignee: REGERON, INC.
    Inventors: Kibum Nam, Kyunyoung Lee, Youngwook Cho, Dahlkyun Oh
  • Patent number: 9598475
    Abstract: The present invention relates to methods for preventing or treating neurological diseases, particularly brain diseases, and improving cognitive functions using a composition comprising stanniocalcin 2 as an active ingredient.
    Type: Grant
    Filed: September 3, 2013
    Date of Patent: March 21, 2017
    Assignee: Regeron, Inc.
    Inventors: Heejae Lee, Jong-Seon Byun, Kyunyoung Lee, Dahlkyun Oh
  • Patent number: 8846611
    Abstract: Disclosed herein is a skin condition-improving composition for topical application to the skin, comprising human growth hormone as an active ingredient, and a method for improving skin conditions using the same. The disclosed composition exhibits various skin conditioning effects, such as acne treatment, wrinkle improvement, dark spot removal, skin elasticity improvement, hair growth stimulation, skin aging prevention, skin moisturization and the proliferation of skin epidermal stem cells.
    Type: Grant
    Filed: April 12, 2006
    Date of Patent: September 30, 2014
    Assignee: Regeron, Inc.
    Inventors: Dahl Kyun Oh, Sang Jung Baik, Kyung Young Lee
  • Publication number: 20140073576
    Abstract: The present invention relates to methods for preventing or treating neurological diseases, particularly brain diseases, and improving cognitive functions using a composition comprising stanniocalcin 2 as an active ingredient.
    Type: Application
    Filed: September 3, 2013
    Publication date: March 13, 2014
    Applicant: REGERON, INC.
    Inventors: Heejae Lee, Jong-Seon Byun, Kyungyoung Lee, Dahlkyun Oh
  • Patent number: 8569240
    Abstract: The present invention relates to methods for preventing or treating neurological diseases, particularly brain diseases, and improving cognitive functions using a composition comprising stanniocalcin 2 as an active ingredient.
    Type: Grant
    Filed: August 14, 2011
    Date of Patent: October 29, 2013
    Assignee: Regeron, Inc.
    Inventors: Heejae Lee, Jong-Seon Byun, Kyung Young Lee, Dahlkyun Oh
  • Patent number: 7951396
    Abstract: Preparing a nanoliposome for encapsulating a protein includes preparing a dispersion by dispersing a phospholipid in an aqueous solution containing the protein, applying a shearing force to the dispersion; adding an additional amount of the phospholipid to the result of the step of applying the shearing force to the dispersion and then applying a shearing force higher than that of the step of applying the shearing force to the dispersion, and repeating the step of adding the additional amount of the phospholipid and applying the higher shearing force with an additional amount of the phospholipid and a shearing force higher than the prior step to obtain a nanoliposome having a desired diameter and encapsulation efficiency.
    Type: Grant
    Filed: March 28, 2006
    Date of Patent: May 31, 2011
    Assignee: Regeron, Inc.
    Inventors: Dahl Kyun Oh, Kyun Young Lee
  • Publication number: 20110021435
    Abstract: The present invention relates to a composition for preventing or treating neurological diseases, particularly brain diseases and improving cognitive functions by inhibiting apoptosis of neuronal cells and/or promoting generation of neuronal cells. The present invention provide a composition for preventing or treating a neurological disease, particularly brain disease, and a composition for improving a cognitive function, which comprises stanniocalcin 2 as an active ingredient.
    Type: Application
    Filed: July 26, 2010
    Publication date: January 27, 2011
    Applicant: REGERON, INC.
    Inventors: Heejae Lee, Jong-Seon Byun, Kyungyoung Lee, Sangjung Baik, Dahlkyun Oh
  • Publication number: 20090053314
    Abstract: An apparatus and a method for the submicronization of proteins using supercritical fluids is provided for feeding the supercritical fluid and feeding a protein solution using a precipitation vessel with a taper shape at its lower part, in which the precipitation vessel accommodates the supercritical fluid and the protein solution to generate submicroparticles of the protein, and a spray nozzle with coaxial arrangement having an outer nozzle for spraying the supercritical fluid and an inner nozzle for spraying the protein solution.
    Type: Application
    Filed: March 10, 2006
    Publication date: February 26, 2009
    Applicant: REGERON, INC.
    Inventors: Dong Jin PYO, Dahl Kyun OH
  • Publication number: 20080213346
    Abstract: Preparing a nanoliposome for encapsulating a protein includes preparing a dispersion by dispersing a phospholipid in an aqueous solution containing the protein, applying a shearing force to the dispersion; adding an additional amount of the phospholipid to the result of the step of applying the shearing force to the dispersion and then applying a shearing force higher than that of the step of applying the shearing force to the dispersion, and repeating the step of adding the additional amount of the phospholipid and applying the higher shearing force with an additional amount of the phospholipid and a shearing force higher than the prior step to obtain a nanoliposome having a desired diameter and encapsulation efficiency.
    Type: Application
    Filed: March 28, 2006
    Publication date: September 4, 2008
    Applicant: REGERON, INC.
    Inventors: Dahlkyun Oh, Kyunyoung Lee
  • Publication number: 20070081963
    Abstract: Disclosed herein is a skin condition-improving composition for topical application to the skin, comprising human growth hormone as an active ingredient, and a method for improving skin conditions using the same. The disclosed composition exhibits various skin conditioning effects, such as acne treatment, wrinkle improvement, dark spot removal, skin elasticity improvement, hair growth stimulation, skin aging prevention, skin moisturization and the proliferation of skin epidermal stem cells.
    Type: Application
    Filed: April 12, 2006
    Publication date: April 12, 2007
    Applicant: REGERON, INC.
    Inventors: Dahl OH, Sang BAIK, Kyung LEE